A Study of Etrasimod in Adults With Crohn’s Disease – Substudy 3
A Multicenter, Randomized, Double-Blind, Parallel-Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenance Therapy for Moderately to Severely Active Crohn’s Disease – Substudy 3
Category & Conditions: Immune System Diseases and Conditions
Medicine: ETRASIMOD
ClinicalTrials.gov Identifier (NCT): NCT04173273
Protocol ID: C5041006 sub study 3
Report Type: Final
Language: English
Open Plain Language Summary Result:
Click here